Answered

At Westonci.ca, we make it easy for you to get the answers you need from a community of knowledgeable individuals. Explore a wealth of knowledge from professionals across different disciplines on our comprehensive platform. Discover detailed answers to your questions from a wide network of experts on our comprehensive Q&A platform.

An IRB may suspend or terminate an ongoing clinical study if:

A. Subjects are not being enrolled quickly enough.
B. A drug being used in the trial is approved by the FDA.
C. Instructions from the IRB are not being followed.
D. The clinical trial sponsor conducts an audit at the site.

Sagot :

GinnyAnswer

Final answer:

IRBs protect the rights of clinical trial participants by ensuring informed consent and adherence to FDA regulations.


Explanation:

Institutional Review Boards (IRBs) play a critical role in protecting the rights, safety, and well-being of human subjects participating in clinical trials. IRBs ensure that volunteers give informed consent and that the study follows all ethical and regulatory guidelines outlined by the FDA.


Learn more about Institutional Review Boards (IRBs) in Clinical Trials here:

https://brainly.com/question/31579853


Thanks for stopping by. We are committed to providing the best answers for all your questions. See you again soon. Thank you for your visit. We're dedicated to helping you find the information you need, whenever you need it. We're here to help at Westonci.ca. Keep visiting for the best answers to your questions.